Meeting Coverage:

American Glaucoma Society

AGS: 2017

Watch out for Baseline Central Visual Field Damage

Show Description +

Speaking on behalf of the African Descent and Glaucoma Evaluation Study (ADAGES), Aakriti Garg, MD, explains why patients with baseline 24-2 central visual field defects require more careful surveillance and potentially more aggressive treatment.

Posted: 3/01/2017

Watch out for Baseline Central Visual Field Damage

Speaking on behalf of the African Descent and Glaucoma Evaluation Study (ADAGES), Aakriti Garg, MD, explains why patients with baseline 24-2 central visual field defects require more careful surveillance and potentially more aggressive treatment.

Posted: 3/01/2017


Please log in to leave a comment.

More From AGS: 2017 Coverage

Glaucoma and Fall Risk

Pradeep Yammanuru Ramulu, MD PhD

Sustained Drug Release

Donald Budenz, MD, MPH